1. Свириденко Н.Ю., Платонова Н.М., Молашенко Н.В. и др. Амиодарон-ассоциированная дисфункция щитовидной железы. Частота развития и возможности коррекции. Кардиология. 2004; 10: 32–8.
2. Деланж Ф. Йодный дефицит в Европе – состояние проблемы на 2002 год. Thyroid Int 2002; 5.
3. Кардиальные и эндокринные аспекты применения амиодарона в современной практике лечения нарушений ритма сердца. Метод. пособие. Под ред. И.И.Дедова, И.Чазова. М., 2012.
4. Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy. C.Newman, A.Price, D.Davies et al. Heart 1998; 79: 121–7.
5. Mechlis S, Lubin E, Laor J et al. Amiodarone-induced thyroid gland dysfunction. Am J Cardiol 1987; 59 (8): 833–5.
6. Nademanee K., Piwonka R., Singh B., Hershman J. Amiodarone and thyroid function. Prog Cardiovasc Dis 1989; 31 (6): 427–37.
7. Eskes S et al. Amiodarone and thyroid. Best Pract Res Clin Endocrinol Met 2009; 23 (6): 735–51.
8. Staubli M., Bischof P., Wimpfheimer C., Studer H.. Amiodarone and the thyroid gland. Schweiz Med Wochenschr 1981; 111 (43): 1590–6.
9. Braverman LE. The physiology and pathophysiology of iodine and the thyroid. Thyroid 2001; 11 (5): 405–6.
10. Eaton S et al. Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography. Clin Endocrinol Oxf 2002; 56 (1): 33–8.
11. de Benoist B, Alnwick B, Delange F et al. Risks of iodine induced hyperthyroidism after correction of iodine deficiency by iodized salt. Thyroid 1999; 9 (6): 545–56.
12. WHO, UNICEF, ICCIDD. Assessment of iodine deficiency disorders and monitoring their elimination. Geneva: WHO, WHO Euro NUT 2001; p. 1–230.
13. Zhao J, Zhao J, van der Haar F et al. Progress in salt iodization and improved iodine nutrition in China, 1995–1999. Food Nutr Bull 2004; 25: 337–43.